On March 15, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition hosted a one-hour webinar on symptomatic treatment in Alzheimer’s disease. During the program leading experts shared their perspectives on the burden of Alzheimer’s disease symptoms on patients and their families, highlighted advances in neurobiology that relate to Alzheimer’s disease symptoms, and updated participants on […]

Take Action

Today Alzheimer’s disease, or AD, is a fatal diagnosis with death preceded by a slow, painful decline and loss of quality of life. The ACT-AD Coalition believes we have the ability to vastly improve the outlook for people with AD and thier caregivers in the next decade and we are committed to working with a […]

Latest News

March 7, 2017: ACT-AD Urges Congress to Provide FDA with $2.8B in FY 2018 August 22, 2016: ACT-AD’s Bens Presents at PDUFA VI Public Meeting June 8, 2016: Prospects Are Promising for Innovation Legislation June 3, 2016: Senate Committee Acts on FY 2017 FDA Appropriations April 19, 2016: NIH Launches Consortium to Study Vascular Links to AD April 18, 2016: FDA […]